1. Executive Summary 2. Introduction 2.1 Sinus Overview 2.1.1 Types of Sinus 2.2 Sinusitis Overview 2.2.1 Types of Sinusitis 2.2.2 Treatment Options 2.3 Drug Eluting Sinus Stents (DESS) Overview 3. US Market Analysis 3.1 US Sinus Surgery Market: An Analysis 3.1.1 US Sinus Surgery Market by Addressable Population 3.1.2 US Sinus Surgery Market by Sinusitis Patients 3.1.3 US Sinus Surgery Market by Chronis Sinusitis Patients 3.1.4 US Sinus Surgery Market by Annual Office Visits 3.1.5 US Sinus Surgery Market by Number of ENT Eligible Patients 3.1.6 US Sinus Surgery Market by Patient Segmentation 3.1.7 US Sinus Surgery Market by Number of Procedures 3.2 US Functional Endoscopic Sinus Surgery (FESS) Market Analysis 3.2.2 US FESS Market by Number of Procedures 3.3 US Balloon Sinus Dilation (BSD) Market Analysis 3.3.1 US BSD Market by Number of Procedures 3.3.2 US BSD Market by Penetration and ASP 3.3.3 US BSD Market by Value 3.3.4 US BSD Market by Segments 3.3.5 US Operating Room (OR) BSD Market Analysis 3.3.6 US Office BSD Market Analysis 3.4 US Drug Eluting Sinus Stent (DESS) Market: An Analysis 3.4.1 US DESS Market by TAM 3.4.2 US DESS Market by Utilization and ASP 3.4.3 US PROPEL Market Analysis 4. Market Dynamics 4.1 Growth Drivers 4.1.1 Rising Per Capita Healthcare Expenditure 4.1.2 Limitations of FESS 4.1.3 Benefits of DESS (PROPEL) 4.1.4 Cost Effectiveness 4.2 Challenges 4.2.1 Use of Oral Steroids and Packaging Material 4.2.2 Reimbursement Issues with Drug Eluting Sinus Stent (DESS) 4.2.3 Dependability on Individual Physician’s Experience 4.2.4 Limited Trials for BSD 4.3 Market Trends 4.3.1 Treatment in Physician’s Office 4.3.2 Move from FESS to BSD 4.3.3 Use of BSD in Frontal Sinuses 4.3.4 3D Technology 4.3.5 Outside US (OUS) DESS Market Opportunity 5. Competitive Landscape 5.1 US Sinus Surgery Market Competitive Landscape 5.1.1 US Sinus Surgery Market Players Financial Comparison 5.2 US BSD Market Competitive Landscape 5.2.1 US BSD Market Share by Players 5.2.2 US BSD Market Segmentation by Players 6. Company Profiling 6.1 Intersect ENT 6.1.1 Business Overview 6.1.2 Financial Overview 6.1.3 Business Strategy 6.2 Medtronic (Xomed) 6.2.1 Business Overview 6.2.2 Financial Overview 6.2.3 Business Strategy 6.3 Entellus Medical 6.3.1 Business Overview 6.3.2 Financial Overview 6.3.3 Business Strategy 6.4 Johnson & Johnson (Acclarent) 6.4.1 Business Overview 6.4.2 Financial Overview 6.4.3 Business Strategy List of Figures Figure 1: Types of Sinuses Figure 2: Types of Sinusitis Figure 3: Treatment Options for Sinusitis Figure 4: US Sinus Surgery Market by Addressable Population; 2015-2021 (Million) Figure 5: US Sinus Surgery Market by Sinusitis Patients and Penetration; 2015-2021 (Patients ‘000) Figure 6: US Sinus Surgery Market by Number of Chronic Sinusitis Patients and Penetration; 2015-2021 Figure 7: US Sinus Surgery Market by Annual Office Visits for CRS; 2015-2021 (‘000) Figure 8 US Sinus Surgery Market by Annual Office Visits for Acute Sinus; 2015-2021 (‘000) Figure 9: US Sinus Surgery Market by Number of ENT Eligible Patients; 2015-2021 (Patients ‘000) Figure 10: US Sinus Surgery Market by Patient Segmentation; 2015-2021 (Patients ‘000) Figure 11 US Sinus Surgery Market by Number of Procedures; 2015-2021 (Procedures ‘000) Figure 12: US FESS Market by Number of Procedures; 2015-2021 (Procedures ‘000) Figure 13: US BSD Market by Number of Procedures; 2015-2020 (Procedures ‘000) Figure 14: US BSD Market by Penetration and ASP; 2015-2021 Figure 15: US BSD Market by Value; 2015-2021 (US$ Million) Figure 16: US BSD Market by Segments; 2015 & 2021 Figure 17: US OR BSD Market by Number of Procedures and Penetration; 2015-2021 Figure 18: US OR BSD Market by Value; 2015-2021 (US$ million) Figure 19: US Office BSD Market by Number of Procedures and Penetration; 2015-2021 Figure 20: US Office BSD Market by Value; 2015-2021 (US$ Million) Figure 21: US DESS Market by Total Addressable Market; 2015-2021 (US$ Million) Figure 22: US DESS Market by Utilization and ASP; 2015-2021 Figure 23: US PROPEL Market by Number of Procedure, Units Sold and Value; 2014-2018 Figure 24: US Per-Capita Healthcare Expenditure; 2007-2014 (US$) Figure 25: Cost Comparison Figure 26: US BSD Market Share by Players Figure 27: US OR BSD Market Share by Players; 2015 & 2021 Figure 28: US Office BSD Market Share by Players; 2015 & 2021 Figure 29: Intersect Revenue; 2012-2015 (US$ Million) Figure 30: Intersect Research and Development Expenditure; 2012-2015 (US$ Million) Figure 31: Medtronic Net Sales; 2011-2015 (US$ Billion) Figure 32: Medtronic Net Sales by Segments; 2015 Figure 33: Entellus Revenue; 2012-2015 (US$ Million) Figure 34: Entellus Revenue by Region; 2015 Figure 35: Johnson & Johnson Total Sales; 2011-2015 (US$ Billion) Figure 36: Johnson & Johnson Sales by Segments; 2015 Figure 37: Johnson & Johnson Sales by Region; 2015 Table 1: US Sinus Surgery Market Players Financial Comparison